PUBLISHER: The Business Research Company | PRODUCT CODE: 1763088
PUBLISHER: The Business Research Company | PRODUCT CODE: 1763088
Panhematin Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts
Panhematin is a hemin-based medication primarily used to treat acute porphyrias, a group of rare metabolic disorders that impact heme biosynthesis. It functions by replenishing heme levels, which helps suppress the production of porphyrin precursors that trigger symptoms.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary dosages of panhematin are 350mg and 313mg. The 350mg dosage is specifically used for managing acute porphyria episodes. Its indications include acute porphyria and other conditions. The medication is used in various settings, such as hospitals and pharmacies.
The panhematin market research report is one of a series of new reports from The Business Research Company that provides panhematin market statistics, including panhematin industry global market size, regional shares, competitors with a panhematin market share, detailed Panhematinmarket segments, market trends, and opportunities, and any further data you may need to thrive in the panhematin industry. This panhematin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The panhematin market size is expected to see rapid growth in the next few years. It will grow to $3,795.4 million in 2029 at a compound annual growth rate (CAGR) of 12%. The growth in the forecast period can be attributed to increasing investment in rare disease research, growth in government funding for rare disease treatments, increasing focus on precision diagnostics, advances in personalized medicine approaches, and expansion of healthcare access in emerging markets. Major trends in the forecast period include the development of alternative and complementary therapies, collaborations for global distribution and marketing, partnerships between pharmaceutical companies and healthcare providers, increasing R&D investments in rare disease treatments, and advances in diagnostic techniques for porphyria.
The increasing diagnosis of genetic disorders is expected to significantly drive the growth of the panhematin market. Genetic disorders, caused by abnormalities in an individual's genetic material, are becoming more frequently diagnosed due to advancements in genetic testing and growing awareness. Early detection enables timely interventions, improving patient outcomes. Panhematin, used for treating acute porphyrias, is vital in managing symptoms such as severe abdominal pain, nausea, and neurological complications that arise from enzyme deficiencies in the heme biosynthesis pathway. As of April 2023, the New England Journal of Medicine reported that 5,500 individuals with severe developmental disorders had identified the genetic causes of their conditions. This rise in diagnoses is expected to increase demand for treatments like panhematin.
Rising healthcare expenditure is a key factor propelling the panhematin market. Increased financial allocation to health services by governments, private sectors, and individuals, driven by an aging population and the prevalence of chronic diseases, allows for better management of rare conditions such as acute porphyria. In May 2024, the Office For National Statistics reported a 5.6% rise in healthcare expenditure from 2022 to 2023. The growing financial resources directed toward healthcare services, including drugs like panhematin, are expected to ensure more patients receive effective treatment, thus fueling market growth.
Increasing cases of blood disorders are contributing to the growth of the panhematin market. Blood disorders, which affect the production and function of blood cells, have been on the rise due to genetic predispositions, lifestyle factors, and an aging population. Panhematin is particularly effective in treating acute intermittent porphyria and similar conditions by providing a synthetic form of heme to bypass defective enzymes in the heme production pathway. This helps reduce the accumulation of toxic porphyrins and alleviates symptoms. For example, the National Health Service (NHS) reported that approximately 17,000 people in England live with sickle cell disease, with 250 new cases diagnosed annually. This increasing incidence of blood disorders further drives the demand for panhematin.
Key player operating in the panhematin market is Horizon Therapeutics plc.
North America was the largest region in the panhematin market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in panhematin report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the panhematin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The panhematin market consists of sales of intravenous (IV) formulations used to treat acute intermittent porphyria (AIP) and related heme synthesis disorders. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Panhematin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on panhematin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for panhematin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The panhematin market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: 350mg; 313mg
- 2) By Indication: Acute Porphyria; Other Indications
- 3) By Application: Hospital; Pharmacy
- Companies Mentioned: Horizon Therapeutics plc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Panhematin Market Characteristics
3. Panhematin Market Biologic Drug Characteristics
- 3.1. Molecule Type
- 3.2. Route Of Administration (ROA)
- 3.3. Mechanism Of Action (MOA)
- 3.4. Safety And Efficacy
4. Panhematin Market Trends And Strategies
5. Panhematin Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
6. Global Panhematin Growth Analysis And Strategic Analysis Framework
- 6.1. Global Panhematin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 6.2. Analysis Of End Use Industries
- 6.3. Global Panhematin Market Growth Rate Analysis
- 6.4. Global Panhematin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 6.5. Global Panhematin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 6.6. Global Panhematin Total Addressable Market (TAM)
7. Global Panhematin Market Pricing Analysis & Forecasts
8. Panhematin Market Segmentation
- 8.1. Global Panhematin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 350mg
- 313mg
- 8.2. Global Panhematin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Acute Porphyria
- Other Indications
- 8.3. Global Panhematin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital
- Pharmacy
9. Global Panhematin Market Epidemiology Of Clinical Indications
- 9.1. Drug Side Effects
- 9.2. Incidence And Prevalence of Clinical Indications
10. Panhematin Market Regional And Country Analysis
- 10.1. Global Panhematin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. Global Panhematin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Asia-Pacific Panhematin Market
- 11.1. Asia-Pacific Panhematin Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 11.2. Asia-Pacific Panhematin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Asia-Pacific Panhematin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Asia-Pacific Panhematin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. China Panhematin Market
- 12.1. China Panhematin Market Overview
- 12.2. China Panhematin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 12.3. China Panhematin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 12.4. China Panhematin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
13. India Panhematin Market
- 13.1. India Panhematin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. India Panhematin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. India Panhematin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. Japan Panhematin Market
- 14.1. Japan Panhematin Market Overview
- 14.2. Japan Panhematin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. Japan Panhematin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. Japan Panhematin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Australia Panhematin Market
- 15.1. Australia Panhematin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.2. Australia Panhematin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Australia Panhematin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. South Korea Panhematin Market
- 16.1. South Korea Panhematin Market Overview
- 16.2. South Korea Panhematin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. South Korea Panhematin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.4. South Korea Panhematin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Western Europe Panhematin Market
- 17.1. Western Europe Panhematin Market Overview
- 17.2. Western Europe Panhematin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Western Europe Panhematin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.4. Western Europe Panhematin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. UK Panhematin Market
- 18.1. UK Panhematin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. UK Panhematin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. UK Panhematin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Germany Panhematin Market
- 19.1. Germany Panhematin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Germany Panhematin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Germany Panhematin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. France Panhematin Market
- 20.1. France Panhematin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. France Panhematin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. France Panhematin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Panhematin Market
- 21.1. Eastern Europe Panhematin Market Overview
- 21.2. Eastern Europe Panhematin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Panhematin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Panhematin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. North America Panhematin Market
- 22.1. North America Panhematin Market Overview
- 22.2. North America Panhematin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. North America Panhematin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.4. North America Panhematin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. USA Panhematin Market
- 23.1. USA Panhematin Market Overview
- 23.2. USA Panhematin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. USA Panhematin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. USA Panhematin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. Canada Panhematin Market
- 24.1. Canada Panhematin Market Overview
- 24.2. Canada Panhematin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. Canada Panhematin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. Canada Panhematin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. South America Panhematin Market
- 25.1. South America Panhematin Market Overview
- 25.2. South America Panhematin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. South America Panhematin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. South America Panhematin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. Middle East Panhematin Market
- 26.1. Middle East Panhematin Market Overview
- 26.2. Middle East Panhematin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. Middle East Panhematin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. Middle East Panhematin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Africa Panhematin Market
- 27.1. Africa Panhematin Market Overview
- 27.2. Africa Panhematin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Africa Panhematin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.4. Africa Panhematin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Panhematin Market Competitive Landscape And Company Profiles
- 28.1. Panhematin Market Competitive Landscape
- 28.2. Panhematin Market Company Profiles
- 28.2.1. Horizon Therapeutics plc. Overview, Products and Services, Strategy and Financial Analysis
29. Global Panhematin Market Pipeline Analysis
- 29.1. High Level Clinic Trail Information
30. Global Panhematin Market Competitive Benchmarking And Dashboard
31. Key Mergers And Acquisitions In The Panhematin Market
32. Recent Developments In The Panhematin Market
33. Panhematin Market High Potential Countries, Segments and Strategies
- 33.1 Panhematin Market In 2029 - Countries Offering Most New Opportunities
- 33.2 Panhematin Market In 2029 - Segments Offering Most New Opportunities
- 33.3 Panhematin Market In 2029 - Growth Strategies
- 33.3.1 Market Trend Based Strategies
- 33.3.2 Competitor Strategies
34. Appendix
- 34.1. Abbreviations
- 34.2. Currencies
- 34.3. Historic And Forecast Inflation Rates
- 34.4. Research Inquiries
- 34.5. The Business Research Company
- 34.6. Copyright And Disclaimer
